Trastuzumab Deruxtecan in Metastatic Breast Cancer with Variable HER2 Expression: the Phase 2 DAISY Trial.
NATURE MEDICINE(2023)
Key words
Breast cancer,Targeted therapies,Biomedicine,general,Cancer Research,Metabolic Diseases,Infectious Diseases,Molecular Medicine,Neurosciences
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined